Cargando…
Predicting aggressive outcome in T1N0M0 breast cancer
Despite the excellent overall prognosis, unpredictable breast cancer recurrences and deaths also occur among T1N0M0 patients. We have evaluated clinically applicable methods for identifying aggressive outcome in T1N0M0 breast cancer. The material is based on aggressive T1N0M0 invasive ductal and lob...
Autores principales: | Kronqvist, P, Kuopio, T, Nykänen, M, Helenius, H, Anttinen, J, Klemi, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409808/ https://www.ncbi.nlm.nih.gov/pubmed/15199391 http://dx.doi.org/10.1038/sj.bjc.6601948 |
Ejemplares similares
-
Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer
por: Kronqvist, P, et al.
Publicado: (2002) -
Securin promotes the identification of favourable outcome in invasive breast cancer
por: Talvinen, K, et al.
Publicado: (2009) -
Separase is a marker for prognosis and mitotic activity in breast cancer
por: Gurvits, Natalia, et al.
Publicado: (2017) -
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness
por: Blot, E, et al.
Publicado: (2003) -
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
por: Faneyte, I F, et al.
Publicado: (2003)